Selected proceedings of the 2009 Summit on Translational Bioinformatics by Lussier, Yves A & Sarkar, Indra Neil
BMC Bioinformatics
Introduction
Selected proceedings of the 2009 Summit on Translational
Bioinformatics
Yves A Lussier*
1 and Indra Neil Sarkar*
2
Address:
1Center for Biomedical Informatics and Section of Genetic Medicine of the Department of Medicine, Institute for Translational
Medicine, Institute for Genomics and Systems Biology, Computational Institute, and Ludwig Center for Metastasis Research; Cancer Research
Center, University of Chicago, 5841 South Maryland Ave, Room N-660B, Mail Code 6091, Chicago, IL 60637, USA and
2Center for Clinical and
Translational Science, University of Vermont, Burlington, VT 05401, USA
E-mail: Yves A Lussier* - lussier@uchicago.edu; Indra Neil Sarkar* - neil.sarkar@uvm.edu
*Corresponding author
from 2009 AMIA Summit on Translational Bioinformatics
San Francisco, CA, USA 15–17 March 2009
Published: 17 September 2009
BMC Bioinformatics 2009, 10(Suppl 9):I1 doi: 10.1186/1471-2105-10-S9-I1
This article is available from: http://www.biomedcentral.com/1471-2105/10/S9/I1
© 2009 Lussier and Sarkar; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background
“It is the responsibility of those of us involved in today’s
biomedical research enterprise to translate the remark-
able scientific innovations we are witnessing into health
gains for the nation [1].” The First Summit on Transla-
tional Bioinformatics (held in 2008) was organized in
response to the call for translational bioinformaticians
that was issued by the Director of the NIH, at a time
there was no national annual conference or symposium
for the presentation and discussion of research work in
Translational Bioinformatics.
This Second Summit built on the success of the first
Summit on Translational Bioinformatics, highlighting
the multidisciplinary nature of this rapidly maturing
research field and providing the opportunity to forge
new transdisciplinary collaborations as the finest minds
of the academia, industry, government and non-profit
sector are brought together. Reflecting on the unique
position of translational bioinformatics in medical
research and healthcare management, the 2009 Scientific
program Committee designed a comprehensive program
comprised of the four original tracks (#1–4) and with
two new ones (#5,6):
1 – Informatics methods for the analysis of molecular
and clinical measurements,
2 – Computational approaches to finding mechan-
isms and therapies for diseases,
3 – Relating and representing phenotypes and
diseases,
4 – Dissecting disease through the study of organ-
isms, evolution and taxonomy,
5 – Informatics concepts, tools, and techniques to
enable integrative translational research,
6 – Informatics methods in genetics discoveries and
clinical practice.
Workshop program
Three hundred and fifty attendees, from 201 distinct
institutions or companies covering 36 states in the US
and 17 other countries, met over three days in San
Francisco, CA. Sixty-three papers and thirty-seven
abstracts were submitted for oral presentation to the
Summit, of which 39 and 28 were respectively accepted
for oral presentation by the Scientific Program Commit-
tee (Additional file 1). In addition to these papers, 3
tutorials, 64 posters and 8 panels were presented.
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Open AccessThe opening session keynote was by Dr. Lynn H. Vogel,
Vice President and Chief Information Officer at The
University of Texas M.D. Anderson Cancer Center in
Houston. Dr. Vogel presented the concepts and invest-
ments underway at the M.D. Anderson Cancer Center for
“Building an IT Architecture to Facilitate Personalized
Medicine”. The second keynote was Dr. Andrea Califano,
Professor of Biomedical Informatics at Columbia Uni-
versity, where he is currently Director of the Center for
the Multiscale Analysis of Genetic Networks (MAGNet –
one of seven NIH-funded National Centers for Biome-
dical Computing), Associate Director for Bioinformatics
of the Herbert Irving Comprehensive Cancer Center
(HICCC), and co-Director of the Center for Computa-
tional Biology and Bioinformatics (C2B2). He presented
on “Using Cancer Interactome for therapeutic target and
associated biomarker discovery”. The closing session
keynote presentation was delivered by Dr. Russ B. Altman,
Professor and Chair of Bioengineering, Professor of
Medicine, Genetics, and Computer Science (by courtesy),
Stanford University, and Principal Investigator of Simbios,
one of the National Centers for Biomedical Computing.
His presentation highlighted a year-in-review of the
literature in Translational Bioinformatics.
Slides from most tutorials, papers, and panels are
publicly available at http://summit2009.amia.org/pre-
sentation-slides
Summary of the selected contributions
The seventeen papers selected for this supplement to
BMC Bioinformatics are extended and improved versions
of the best papers accepted to the 2009 Summit of
Translational Bioinformatics. In the following para-
graphs, we briefly describe them.
Six of these papers deal with the science of network
analyses applied to the Translational Bioinformatics
field. Chang and Ramoni show how Bayesian Networks
(BN) can improve on current microarray analyses by
generating a predictor that does not require the biased
adjustment of parameters of the current state if the art.
An unbiased BN predictor of aortic aneurysm diagnosis
is provided as proof of concept [2]. Lee et al.s h o wh o w
protein interactions and gene expression can be com-
bined for predicting novel joint networks ignored by
array analyses alone[3]. Bhavnani et al. provide a
molecular classification of renal diseases showing gene
expression similarities rather than morphological simi-
larities, perhaps illustrative of shared expression under-
pinning organ-specific phenotypic networks [4]. Butte’s
group illustrates how non-trivial correlations between
two physiological measurements in intensive care unit
can be more reliable for prognosis than single
measurements or laboratory values suggesting an
unbiased and systematic approach to discovery of
novel complex prognosis markers [5]. Dean et al.
demonstrated how evolutionary conserved binding
sites of transcriptional factors used jointly with expres-
sion profiling can be used to subsequently construct cis-
regulatory expression modules in osteocytes [6]. Yang
and Lussier propose a novel and robust algorithm to
identify epigenetic regulation derived from co-expression
networks and epigenetic targets in the literature, with a
specific evaluation in terms of significance and accuracy
in the context of Acute Lymphobalstic Leukemia [7].
Two papers are in the area of decision making relying on
genomic or complex multiscale analyses. The PAPAyA
framework integrates the complexity of multiscale
analyses inclusive of clinical prognosis, histopathologi-
cal morphology and genomic measurements to facilitate
multiscale biomarker development, hypothesis genera-
tion and decision support [8]. Overby provides a
framework for question answering with genomic and
clinical knowledge from the Unified Medical Language
System [9].
Three papers were highlighted in the area of large-scale
repositories in support of genomic medicine. Ohno-
Machado’s group create a comprehensive and consistent
annotation system for the context in which samples are
annotated in the NIH Gene Expression Omnibus
database (GEO), inclusive of tissue, cell line, histo-
pathological type, and subject characteristics such as
demographics, treatment, or survival. They report an
implementation of over 6,000 samples extracted from
GEO [10] and inter-rater agreement of 92% [11]. Tarczy-
Hornoch’s group created SNPit, a database that provides
some guidance on the variability of SNPs as an indicator
of an adequate measure for clinical relevance [12].
Three papers focused on phenotypic representation, their
ontologies and their coding in narratives. South et al.
provided a practical approach to text processing of
phenotypic information in clinical records [13], while
Wang, Hripcsak and Friedman provide an algorithm
based on mutual information to disclose interdepen-
dencies that may not be linear between environmental
(medication) and phenotypic data [14]. Musen’s group
provides a novel algorithm for term-based ontology
annotation that performs better than the NIH gold
standard MetaMap[15].
Finally, three papers were chosen in the unrelated areas
of fMRI, structural biology and rule learning. Jin et al.
demonstrated a feature-learning algorithm to identify
patterns of voxels in fMRI associate to phenotypic
classification [16]. Lustgard used an ontology-anchored
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learning algorithms designed to discover novel ones in a
proteomic datasets [17]. Shivakumar and Krauthammer
use structural similarity to identify substitute sensitivity
profiles for medications that are not included in cancer
screens, aiming to potentially increase the relevance of
existing anti-cancer drug screens [18].
The next Summit on Translational Bioinformatics will be
held in 2010 in San Francisco.
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